SG11202101320RA - Paracetamol liquid suspensions - Google Patents

Paracetamol liquid suspensions

Info

Publication number
SG11202101320RA
SG11202101320RA SG11202101320RA SG11202101320RA SG11202101320RA SG 11202101320R A SG11202101320R A SG 11202101320RA SG 11202101320R A SG11202101320R A SG 11202101320RA SG 11202101320R A SG11202101320R A SG 11202101320RA SG 11202101320R A SG11202101320R A SG 11202101320RA
Authority
SG
Singapore
Prior art keywords
liquid suspensions
paracetamol
paracetamol liquid
suspensions
liquid
Prior art date
Application number
SG11202101320RA
Inventor
Mauro Cavinato
Karin Gerola
Original Assignee
Gsk Consumer Healthcare Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsk Consumer Healthcare Sarl filed Critical Gsk Consumer Healthcare Sarl
Publication of SG11202101320RA publication Critical patent/SG11202101320RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202101320RA 2018-08-28 2019-08-22 Paracetamol liquid suspensions SG11202101320RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862723561P 2018-08-28 2018-08-28
PCT/EP2019/072445 WO2020043587A1 (en) 2018-08-28 2019-08-22 Paracetamol liquid suspensions

Publications (1)

Publication Number Publication Date
SG11202101320RA true SG11202101320RA (en) 2021-03-30

Family

ID=67766153

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101320RA SG11202101320RA (en) 2018-08-28 2019-08-22 Paracetamol liquid suspensions

Country Status (9)

Country Link
US (1) US11786462B2 (en)
EP (1) EP3843703A1 (en)
CN (1) CN112888427A (en)
AU (2) AU2019328411B2 (en)
BR (1) BR112021003544A2 (en)
CO (1) CO2021002721A2 (en)
PE (1) PE20211218A1 (en)
SG (1) SG11202101320RA (en)
WO (1) WO2020043587A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112274483A (en) * 2020-10-28 2021-01-29 河北冀衡药业股份有限公司 Acetaminophen suspension drop and preparation method thereof
WO2022178018A1 (en) * 2021-02-19 2022-08-25 Nevakar Injectables Inc. Liquid unit dosage forms for treatment of pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
EP0620001A1 (en) 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US7300670B2 (en) * 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
DE10234784A1 (en) * 2002-07-30 2004-02-19 Günenthal GmbH Pharmaceutical dosage form that can be administered intravenously
US20060093629A1 (en) * 2004-10-29 2006-05-04 Buehler Gail K Dye-free pharmaceutical suspensions and related methods
CA2610480A1 (en) * 2005-06-03 2007-05-10 Scott Jenkins Nanoparticulate acetaminophen formulations

Also Published As

Publication number Publication date
EP3843703A1 (en) 2021-07-07
BR112021003544A2 (en) 2021-05-18
AU2019328411A1 (en) 2021-03-11
AU2019328411B2 (en) 2022-02-10
WO2020043587A1 (en) 2020-03-05
US20210251896A1 (en) 2021-08-19
CO2021002721A2 (en) 2021-05-20
CN112888427A (en) 2021-06-01
US11786462B2 (en) 2023-10-17
PE20211218A1 (en) 2021-07-05
AU2022202456A1 (en) 2022-05-05

Similar Documents

Publication Publication Date Title
GB201707674D0 (en) Porous liquids
AU201817730S (en) Sunglasses
SG11202105443PA (en) Liquid level determination
EP3756002C0 (en) Liquid chromatography technique
GB201807286D0 (en) New use
PL3137056T3 (en) Bismuth-containing liquid pharmaceutical suspensions
CA186558S (en) Liquid container
SG11202101320RA (en) Paracetamol liquid suspensions
GB2580116B (en) Gyroscope
SG10202005812YA (en) Gas-Dissolved Liquid Manufacturing Device
CA187698S (en) Liquid container
CA187700S (en) Liquid container
CA186599S (en) Dropper
PL3831176T3 (en) Suspension device
GB202009385D0 (en) Cleaning liquid
EP3819231C0 (en) Application container
GB201812364D0 (en) Gyroscope
GB201919437D0 (en) Cleaning fluid
GB201813417D0 (en) Liquid improvement
SG11202013257RA (en) Liquid process assembly
PL3643173T3 (en) Method for the application of liquid
GB201915266D0 (en) Suspension device
SG11202101593YA (en) Etching liquid
GB2572450B (en) Liquid Vaporiser Assembly
SG11202011746UA (en) Application container